Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM All-Share

410.00p
   
  • Change Today:
    -20.00p
  • 52 Week High: 445.00
  • 52 Week Low: 295.00
  • Currency: UK Pounds
  • Shares Issued: 47.31m
  • Volume: 52,116
  • Market Cap: £193.98m
  • RiskGrade: 180
  • Beta: 0.04

Tristel Overview

We are an infection prevention company. The entire purpose of our business is to prevent the transmission of microbes from one object or person to another. We achieve our mission by applying a very powerful biocidal chemistry – chlorine dioxide – to the target environmental surface or medical device. We are one of a very few companies worldwide that can legitimately claim to be exclusively an infection prevention business.
Competitors: Trellus Health, Open Orphan , Mediclinic International , Cambridge Cognition Holdings, Sourcebio International, Sensyne Health, CareTech Holding, Diaceutics

Key Personnel

CEO: Paul Christopher Swinney
Executive Director: Bart Leemans
Finance Director: Elizabeth Dixon
Independent Non-Executive Director: Isabel J S Napper
Independent Non-Executive Director: Caroline Stephens
Non-Executive Chairman: Bruno Holthof
Senior Independent Non-Executive Director: Tom Jenkins
Non-Executive Dir: David Orr

Contact Details

Address: Unit 1B Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire , United Kingdom, CB8 7NY
Phone: 44 (0) 1638 721500
Fax: 44 (0) 1638 721911
Website: http://www.tristel.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B07RVT99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 410.00p
Change Today -20.00p
% Change -4.65 %
52 Week High 445.00
52 Week Low 295.00
Volume 52,116
Shares Issued 47.31m
Market Cap £193.98m
Beta 0.04
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.53% below the market average95.53% below the market average95.53% below the market average95.53% below the market average95.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
66.02% above the market average66.02% above the market average66.02% above the market average66.02% above the market average66.02% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Income
98.54% below the market average98.54% below the market average98.54% below the market average98.54% below the market average98.54% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
95.56% below the market average95.56% below the market average95.56% below the market average95.56% below the market average95.56% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Mar-23 17-Nov-22
Paid 11-Apr-23 16-Dec-22
Amount 2.62p 3.93p

Trades for 03-Oct-2023

Time Volume / Share Price
16:14 254 @ 405.11p
16:11 11,406 @ 410.00p
16:08 940 @ 405.00p
15:42 90 @ 405.11p
15:28 96 @ 409.90p

Tristel Key Personnel

CEO Paul Christopher Swinney
Finance Director Elizabeth Dixon

Top of Page